Abstract: Provided is a novel compound and use thereof which has an excellent immunological regulation ability while not exhibiting toxicity in vivo, and has no nephrotoxicity and rather has a kidney protective effect, and thus can be used for the treatment of immune diseases such as autoimmune diseases caused by abnormal regulation of various immune responses, inflammatory diseases, and transplant rejection diseases. A transplant rejection avatar animal model was confirmed to be humanized, by confirming an increase in serum creatinine, an indicator of transplant rejection in a patient, an increase in human CD4-positive cells, and infiltration of inflammatory cytokine IL-17 into kidney tissue of the animal model. It was confirmed that, when an immunosuppressant is administered, the increased serum creatinine, human CD4-positive cells, and the infiltration of inflammatory cytokine IL-17 are reduced, and thus an animal model, in which the immune status of a patient is reflected, is effectively constructed.

Abstract: According to one embodiment, a method for remotely controlling peripheral devices in a mobile communication terminal includes acquiring a profile for a controlled peripheral device, configuring a control application for the controlled peripheral device based on the acquired profile, and controlling the controlled peripheral device using the configured control application.

Abstract: The present invention relates to a composition for preventing or treating transplantation rejection or a transplantation rejection disease, comprising a novel compound and a calcineurin inhibitor. A co-administration of the present invention 1) reduces the activity of pathogenic Th1 cells or Th17 cells, 2) increases the activity of Treg cells, 3) has an inhibitory effect against side effects, such as tissue damage, occurring in the sole administration thereof, 4) inhibits various pathogenic pathways, 5) inhibits the cell death of inflammatory cells, and 6) increases the activity of mitochondria, in an in vivo or in vitro allogenic model, a transplantation rejection disease model, a skin transplantation model, and a liver-transplanted patient, and thus inhibits transplantation rejection along with mitigating side effects possibly occurring in the administration of a conventional immunosuppressant alone.

Abstract: One embodiment of the invention provides an image correction method comprising: providing a first image; providing a first image; providing viewpoint information about a viewpoint which observes the first image; dividing the first image into two or more segmented images along a horizontal direction of the first image; and providing a second image converted from the first image by converting each of the two or more segmented images based on the viewpoint information and vertical lengths of each of the segmented images.

Abstract: One embodiment of the invention provides an image correction method comprising: providing a first image; providing a first image; providing viewpoint information about a viewpoint which observes the first image; dividing the first image into two or more segmented images along a horizontal direction of the first image; and providing a second image converted from the first image by converting each of the two or more segmented images based on the viewpoint information and vertical lengths of each of the segmented images.

Abstract: The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-?, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.

Abstract: According to one embodiment, a method for remotely controlling peripheral devices in a mobile communication terminal includes acquiring a profile for a controlled peripheral device, configuring a control application for the controlled peripheral device based on the acquired profile, and controlling the controlled peripheral device using the configured control application.

Abstract: According to one embodiment, a method for remotely controlling peripheral devices in a mobile communication terminal includes acquiring a profile for a controlled peripheral device, configuring a control application for the controlled peripheral device based on the acquired profile, and controlling the controlled peripheral device using the configured control application.

Abstract: The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-?, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.

Abstract: The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-?, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.

Abstract: The present invention relates to a long-range discernible image generating apparatus and a method of operating the same, and particularly, to a long-range discernible image generating apparatus and a method of operating the same, which are capable of providing improved legibility. According to an embodiment of the present invention, a long-range discernible image generating apparatus is provided.

Abstract: A UI providing apparatus is disclosed. The present user interface (UI) providing apparatus comprises: a reception unit for receiving user information using near field communication from a communication device in which the user information is stored; a control unit for configuring a UI so as to respond to information about the type and the degree of a user's disability derived on the basis of the user information; and an output unit for outputting the configured UI.

Abstract: An electronic device includes a display; a communication interface; a camera; and a controller configured to control the display to display content; control the camera to capture an image of a user who watches the electronic device while displaying the content; control to obtain information regarding a posture of the user based on the captured image; control to determine whether the posture of the user is acceptable based on the obtained information regarding the posture of the user; and based on determining that the posture of the user is not acceptable, control the communication interface to transmit the captured image of the user to another device.

Abstract: Provided is a novel compound capable of effectively preventing and treating immune diseases and a use thereof. The novel compound of the present subject matter has effects of inhibiting the production of inflammatory cytokines, increasing the activity of regulatory T cells having immunoregulatory functions, inhibiting the production of auto-antibodies to regulate excessive immune responses, and inhibiting the differentiation of osteoclasts, and thus can be used for treating immune diseases, such as autoimmune disease, inflammatory disease, and transplant rejection diseases, which are caused by abnormal regulation of various kinds of immune response.

Abstract: The present invention relates to a novel compound capable of effectively preventing and treating immune diseases and a use thereof.

Abstract: The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-?, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.

Abstract: An electronic device includes a display; a communication interface; a camera; and a controller configured to control the display to display content; control the camera to capture an image of a user who watches the electronic device while displaying the content; control to obtain information regarding a posture of the user based on the captured image; control to determine whether the posture of the user is acceptable based on the obtained information regarding the posture of the user; and based on determining that the posture of the user is not acceptable, control the communication interface to transmit the captured image of the user to another device.

Abstract: The present invention relates to a long-range discernible image generating apparatus and a method of operating the same, and particularly, to a long-range discernible image generating apparatus and a method of operating the same, which are capable of providing improved legibility. According to an embodiment of the present invention, a long-range discernible image generating apparatus is provided.

Abstract: According to one embodiment, a method for remotely controlling peripheral devices in a mobile communication terminal includes acquiring a profile for a controlled peripheral device, configuring a control application for the controlled peripheral device based on the acquired profile, and controlling the controlled peripheral device using the configured control application.

Abstract: An electronic device includes a camera configured to capture an image of a user which is watching the electronic device; a controller configured to obtain information regarding a posture of the user based on the captured image, determine whether the posture of the user is acceptable based on the obtained information regarding the posture of the user; and a display configured to display posture correcting content based on a result of the determination.